Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M. Marty, Cyrus Badshah, Per Ljungman et al.|New England Journal of Medicine|2017Cited by 1.2k
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronavirusesJason T. Ladner, John A. Altin, Sierra N. Henson et al.|Cell Reports Medicine|2021Cited by 219
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A. Stadtmauer, Elchonon M. Berkowitz, Jo‐Anne H. Young et al.|Blood|2014Cited by 177
Epidemiology and treatment approaches in management of invasive fungal infectionsJames I. Ito, Kriengkauykiat, Sanjeet Dadwal|Clinical Epidemiology|2011Cited by 154
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT StudyRoy F. Chemaly, Ella Ariza‐Heredia, Lynn El Haddad et al.|Clinical Infectious Diseases|2020Cited by 109